<DOC>
	<DOCNO>NCT03101696</DOCNO>
	<brief_summary>The gold standard induce coronary hyperemia measurement fractional flow reserve ( FFR ) , coronary flow reserve ( CFR ) index microcirculatory resistance ( IMR ) adenosine , exert several side effect due unspecific action adenosine receptor . The specific A2a-receptor agonist , regadenoson , show dilate coronary artery enable FFR measurement . The aim study evaluate whether simultaneous measurement FFR , CFR IMR feasible , safe effective within regadenoson-induced hyperemia .</brief_summary>
	<brief_title>Determination Coronarphysiological Parameters With Method Thermodillution</brief_title>
	<detailed_description>Fractional flow reserve ( FFR ) , coronary flow reserve ( CFR ) index microcirculatory resistance ( IMR ) provide significant information conductance coronary macro- microcirculation . FFR-based functional assessment coronary artery disease proven superior purely morphologic assessment thereby guide therapy decision . IMR pressure-temperature derive parameter quantify microcirculatory resistance , proven relatively independent epicardial stenosis severity take collateral flow account . IMR increase patient acute myocardial infarction microvascular obstruction ( MVO ) assess contrast-enhanced CMR predict leave ventricular function enddiastolic volume 6 month independently initial infarct size . Most interestingly , even absence obstructive coronary artery disease , IMR elevate 20 % patient present chest pain . The clinical meaning finding elucidate . FFR , CFR IMR measure condition minimal coronary resistance need coronary hyperemia . The current `` gold standard '' induce hyperemia assessment coronary conductance adenosine . However , adenosine know cause side effect ( bronchospasm disturbance atrioventricular conduction ) due unselective action adenosine receptor . Besides , adenosine require body weight adapt dose continuous infusion . However , alternative route like intracoronary injection show good correlation compare intravenous route side effect reduce . In contrast , regadenoson , specific A2A receptor agonist , exhibit negligible side effect . It administer intravenously non-body weight adapt bolus via peripheral vein without need transfemoral delivery . Thus , patient transradial access cardiac catheterization might benefit inducing hypermedia via peripheral vein . It already show regadenoson increase coronary blood flow yield comparable value FFR index perfusion SPECT . However , duration stability regadenoson-induced hyperemia might insufficient simultaneous measurement FFR , CFR IMR , test far . The aim present study evaluate whether simultaneous measurement parameter FFR , CFR IMR regadenoson-induced hyperemia feasible , safe effective patient stable coronary artery disease undergo transradial procedure</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>Coronary angiography indication FFR measurement angiography without pathological result explain patient ' symptom intermediate stenosis ( 5070 % ) &lt; 18 year Hypersensitivity towards regadenoson hemodynamic instability severe hypotension acute myocardial ischemia AV block IIIII</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>coronary angiography</keyword>
	<keyword>coronary conductance</keyword>
	<keyword>hyperemia</keyword>
	<keyword>regadenoson</keyword>
	<keyword>fractional flow reserve</keyword>
	<keyword>coronary flow reserve</keyword>
	<keyword>index microcirculatory resistance</keyword>
</DOC>